Accumulated evidence suggests that a high plasma aldosterone concentration and mineralocorticoid receptor (MR) overactivation play a pathophysiological role in metabolic syndromes and several cardiorenal diseases via pro-inflammatory and pro-fibrotic signaling-mediated injuries in the tissues and organs [8, 9]. This evidence concerns the gene NR3C2 and metabolic syndrome.